News zum Sektor Gesundheit aus Israel

Es sind 102 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1559 Aktien zum Sektor Gesundheit bekannt.

>Gesundheit News Israel
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belarus
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldau
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

13.04.26 - 13:33	Newly Published U.S. Expert Consensus Aligns with MediWound′s Strategy for Chronic Wound Debridement (GlobeNewswire EN)
	Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound Debridement...

13.04.26 - 13:03	InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
	Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for......

13.04.26 - 13:03	CollPlant Issues Letter to Shareholders (PR Newswire)
	REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary plant-derived recombinant human collagen (rhCollagen), is pleased to issue the following letter......

10.04.26 - 15:31	Israel threatens healthcare as it continues to attack Lebanon (Al Jazeera)
	Israel threatens healthcare as it continues to attack Lebanon...

09.04.26 - 23:42	Hospitals in Beirut struggle to deal with casualties after Israeli attacks (Al Jazeera)
	Doctors warn of worsening crises as vital supplies run low and Israeli attacks devastate Beirut and surrounding areas....

09.04.26 - 13:33	Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol (PR Newswire)
	98% of drugs do not reach the brain, as the blood–brain barrier (BBB) separates peripheral blood circulation from the central nervous system (CNS). Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary formulation of Aramchol which targets the brain. By......

08.04.26 - 14:33	Ondo Global Markets Tokenizes Enlivex′s Ordinary Shares (GlobeNewswire EN)
	Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that Ondo Finance (“Ondo”) has launched ENLVon, the Ondo tokenized representation of ENLV's ordinary shares on Ondo's Global Markets platform....

07.04.26 - 13:03	MediWound to Present New EscharEx® Data at Leading Wound Care Conferences (GlobeNewswire EN)
	MediWound to Present New EscharEx® Data at Leading Wound Care Conferences ...

06.04.26 - 19:54	Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners (PR Newswire)
	MIAMI, April 6, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Israel-based Entera Bio Ltd. (Nasdaq: ENTX), a clinical-stage biotechnology company focused on the development of oral peptide and protein replacement therapies, in a $10 million private placement led by......

06.04.26 - 15:21	NeuroSense Granted Brazilian Patent Covering PrimeC Composition (PR Newswire)
	Patent Protection Through October 2042 Follows prior patent grants in the U.S. and Australia Further strengthens NeuroSense's global intellectual property portfolio CAMBRIDGE, Mass., April 6, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"),......

06.04.26 - 07:15	Doctor warns that Israel is ravaging Lebanon′s health care system (AP)
	Um den gesamten Artikel unter apnews.com zu lesen, klicken Sie bitte auf die Überschrift...

06.04.26 - 07:15	After Gaza devastation, Israeli attacks on Lebanon′s health care system feel familiar for many (AP)
	Um den gesamten Artikel unter apnews.com zu lesen, klicken Sie bitte auf die Überschrift...

04.04.26 - 14:18	Medikamentenmangel in Gaza: Ärzte ohne Grenzen: Israelische Blockade wird zu Todesfällen führen (N-TV)
	Seit Anfang des Jahres kann Ärzte ohne Grenzen keine wichtigen Medikamente mehr in den Gazastreifen bringen, obwohl diese bereitstehen. Die Hilfsorganisation warnt vor gravierenden Folgen und sieht die israelischen Behörden in der Verantwortung....

03.04.26 - 16:57	NeuroSense Therapeutics receives Nasdaq notices over listing requirements (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.04.26 - 16:03	NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements (PR Newswire)
	Notifications have no immediate effect on the listing or trading of the Company's securities on Nasdaq Nasdaq has provided the Company until September 29, 2026 to regain compliance with both requirements The Company is actively evaluating actions to regain compliance, with a clear focus......

03.04.26 - 10:06	How Israel is destroying healthcare infrastructure in southern Lebanon (Al Jazeera)
	Israel's attacks on hospitals, medical centres and healthcare workers are fuelling displacement and a health crisis....

02.04.26 - 21:27	MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million (GlobeNewswire EN)
	MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million...

02.04.26 - 15:06	Entera Bio prices $10M direct investment, sees up to $24.5M in total proceeds (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

02.04.26 - 14:48	Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds (GlobeNewswire EN)
	TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that it has entered into a securities purchase agreement for a private placement (the “Private Placement”) led by funds affiliated with BVF Partners L.P. (“BVF”)....

31.03.26 - 22:18	Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 (PR Newswire)
	TEL AVIV, Israel, March 31, 2026 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, today announced that it has filed its Annual Report on......

>weitere News anzeigen...